Showing 1 to 3 of 3 results


China Urges Increased COVID-19 Prevention Efforts Amid Rising Positivity Rates"
China's COVID-19 positivity rate rose sharply between March 31 and May 4, prompting leading respiratory disease expert Zhong Nanshan to urge increased prevention and treatment efforts, particularly for seniors, recommending early medication within 48 hours of symptom onset, while acknowledging the l...
China Urges Increased COVID-19 Prevention Efforts Amid Rising Positivity Rates"
China's COVID-19 positivity rate rose sharply between March 31 and May 4, prompting leading respiratory disease expert Zhong Nanshan to urge increased prevention and treatment efforts, particularly for seniors, recommending early medication within 48 hours of symptom onset, while acknowledging the l...
Progress
24% Bias Score


China to Develop Child-Specific COVID-19 Antibodies
Dr. Zhong Nanshan announced his team is developing COVID-19 antibodies for children under 5 due to insufficient research and safety data on current treatments; COVID-19 positivity rates have increased from 7.5 percent to 16.2 percent in outpatient cases between March 31 and May 4, underscoring the u...
China to Develop Child-Specific COVID-19 Antibodies
Dr. Zhong Nanshan announced his team is developing COVID-19 antibodies for children under 5 due to insufficient research and safety data on current treatments; COVID-19 positivity rates have increased from 7.5 percent to 16.2 percent in outpatient cases between March 31 and May 4, underscoring the u...
Progress
44% Bias Score

China's COVID-19 Cases Remain High, Prompting Urgent Treatment Call
A leading Chinese respiratory disease expert warns of persistently high COVID-19 infection rates nationwide, urging prompt treatment for seniors and highlighting limited research on treatments for children under 5, while emphasizing ongoing development of new influenza medications.

China's COVID-19 Cases Remain High, Prompting Urgent Treatment Call
A leading Chinese respiratory disease expert warns of persistently high COVID-19 infection rates nationwide, urging prompt treatment for seniors and highlighting limited research on treatments for children under 5, while emphasizing ongoing development of new influenza medications.
Progress
24% Bias Score
Showing 1 to 3 of 3 results